Fat overload syndrome in pediatric patients: One case and ten at risk

Puthita Saengpanit1, Phakwan Laohathai1, Supawan Kunnangja1

  • 1Division of Nutrition, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Insights

Fat overload syndrome, a rare complication of intravenous lipid emulsions in parenteral nutrition, requires prompt recognition and intervention. Careful administration and monitoring of pediatric patients are crucial to prevent recurrence and improve outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Clinical nutrition
  • Patient safety

Background:

  • Fat overload syndrome is a rare but serious complication of intravenous lipid emulsions used in parenteral nutrition.
  • Prompt identification of causes, symptom recognition, complication monitoring, and management are vital for pediatric patients.

Purpose of the Study:

  • To review the etiologies, complications, management, and outcomes of fat overload syndrome in pediatric patients.
  • To identify risk factors and strategies for preventing recurrence of fat overload syndrome.

Main Methods:

  • A retrospective chart review of 11 pediatric patients who received lipid emulsions at excessive infusion rates over five years.
  • Data collected included patient demographics, lipid emulsion details, clinical presentations, laboratory results, management, and outcomes.

Main Results:

  • Eleven pediatric patients (9 months to 15 years) were included. Causes included incorrect infusion pump programming and inadvertent switching of solutions.
  • One patient developed fat overload syndrome with oliguria and metabolic acidosis. Management involved discontinuing lipid emulsions and supportive care.
  • Most patients had no complications; four required additional supportive interventions.

Conclusions:

  • Fat overload syndrome, though uncommon, necessitates prompt recognition and intervention in pediatric patients receiving parenteral nutrition.
  • Careful administration of parenteral lipids and vigilant monitoring of at-risk individuals are essential.
  • Root cause analysis is critical for preventing future incidents and improving patient safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
269
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
198
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
260
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K